PARD (Poniard Pharmaceuticals) Other Operating Expense: $1.22 Mil (TTM As of Sep. 2011)


What is Poniard Pharmaceuticals Other Operating Expense?

Poniard Pharmaceuticals PARD Other Operating Expense is $1.22 Mil as of Sep. 2011.

Poniard Pharmaceuticals's Other Operating Expense for the three months ended in Sep. 2011 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2011 was $1.22 Mil.

Poniard Pharmaceuticals's quarterly Other Operating Expense stayed the same from Mar. 2011 ($0.00 Mil) to Jun. 2011 ($0.00 Mil) but then increased from Jun. 2011 ($0.00 Mil) to Sep. 2011 ($0.00 Mil).

Poniard Pharmaceuticals's annual Other Operating Expense stayed the same from Dec. 2008 ($-0.00 Mil) to Dec. 2009 ($-0.00 Mil) but then increased from Dec. 2009 ($-0.00 Mil) to Dec. 2010 ($1.22 Mil).

Poniard Pharmaceuticals Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Other Operating Expense Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 -0.11 -0.00 -0.00 1.22

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.22 0.00 0.00 0.00

Poniard Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $1.22 Mil mean?
Poniard Pharmaceuticals (PARD) has a Other Operating Expense of $1.22 Mil as of Sep. 2011. Other operating expenses that a company records on its income statement. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Other Operating Expense too high?
Poniard Pharmaceuticals' current Other Operating Expense is $1.22 Mil.
How does Poniard Pharmaceuticals' Other Operating Expense compare to OBMP and NSPX?
Poniard Pharmaceuticals' Other Operating Expense of $1.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Other Operating Expense is $1.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Other Operating Expense of $1.22 Mil. The current Other Operating Expense is $1.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Other Operating Expense is $1.22 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.